Bransen Pharmaceuticals Private Limited
About Bransen Pharmaceuticals Private Limited
Data last updated:
Bransen Pharmaceuticals Private Limited is a private limited company based in New, Delhi, India. It was incorporated on 16 June 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC415702.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manmohan Singh Negi and Manju.
Its last annual general meeting (AGM) was held on 14 October 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No – F – 12/8 C 3rd Floor, Joga Bai Extn Okhla, New, Delhi, India – 110025.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.8 Lakh. For the same year it recorded a net profit of ₹8,326 (net margin 1.7%) and EBITDA of ₹16,187 (EBITDA margin 3.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No – F – 12/8 C 3rd Floor, Joga Bai Extn Okhla, New, Delhi, India – 110025
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bransen Pharmaceuticals Private Limited
The main business activity of Bransen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Bransen Pharmaceuticals Private Limited
Bransen Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manmohan Singh Negi | Director | 17 May 2024 | 2 Years 4 Months | Current |
| Manju | Director | 16 Jun 2023 | 3 Years 3 Months | Current |
Financials of Bransen Pharmaceuticals Private Limited FY 2024 filings available
Bransen Pharmaceuticals Private Limited reported revenue of ₹4.8 Lakh for FY 2024.
Financial Statement Summary of Bransen Pharmaceuticals Private Limited
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | ₹16,187 |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | ₹8,326 |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Bransen Pharmaceuticals Private Limited
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | 3.4% |
| Net Profit Margin | 1.7% |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bransen Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bransen Pharmaceuticals Private Limited
Bransen Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bransen Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Bransen Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Bransen Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Bransen Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bransen Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bransen Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bransen Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Bransen Pharmaceuticals Private Limited
Frequently Asked Questions about Bransen Pharmaceuticals Private Limited
Bransen Pharmaceuticals is an active private limited company based in New, Delhi, India. It was incorporated on 16 June 2023 (3+ years old) and is registered under CIN U46497DL2023PTC415702.
Bransen Pharmaceuticals reported revenue of ₹4.8 Lakh for FY 2024.
Bransen Pharmaceuticals has 2 current directors:
- Manmohan Singh Negi - Director
- Manju - Director
Bransen Pharmaceuticals reported a net profit of ₹8,326 (net margin 1.7%) and EBITDA of ₹16,187 (EBITDA margin 3.4%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Bransen Pharmaceuticals is U46497DL2023PTC415702. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bransen Pharmaceuticals was incorporated on 16 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The registered office of Bransen Pharmaceuticals is at H.No – F – 128 C 3rd Floor, Joga Bai Extn Okhla, New, Delhi, India – 110025.
Bransen Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
No. Bransen Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.